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CENTRAL AUDITORY EVALUATION 
IN MULTIPLE SCLEROSIS
Case report
Eliane Schochat1, Carla G. Matas2, Seisse Gabriela G. Sanches3,
Renata M.M. Carvallo1, Sandro Matas4
ABSTRACT - Herein, we report a case of multiple sclerosis in which peripheral and central hearing, were
evaluated through early (brainstem), middle and late auditory evoked potentials before and after corti-
costeroid therapy. Auditory evaluation revealed better performance on all post-treatment tests. In this
case, central auditory function tests (behavioral and electrophysiological) identified the location of the
impairment (brainstem), which was in agreement with the patient complaint. The speech in noise test and
brainstem auditory evoked potentials are definitely appropriate in confirming brainstem lesions.
KEY WORDS: multiple sclerosis, electrophysiology, auditory perceptual disorders.
Avaliação auditiva central na esclerose múltipla: relato de caso
RESUMO - Relatamos caso de esclerose múltipla em que foi feita avaliação da audição periférica e central
utilizando os potenciais evocados auditivos de curta, média e longa latência antes e depois da terapia com
corticosteróides. A avaliação auditiva revelou melhor desempenho em todos os testes após o tratamento.
Neste caso, os testes que avaliam a função central da audição (comportamental e eletrofisiológico) foram
capazes de identificar o local da lesão (tronco encefálico), o que estava de acordo com as queixas do
paciente. Os testes de fala com ruído e os potenciais evocados auditivos de curta latência são apropriados
para revelar lesões de tronco encefálico.
PALAVRAS-CHAVE: esclerose múltipla, eletrofisiologia, distúrbios perceptuais auditivos.
The advent of magnetic resonance imaging (MRI)
techniques represents a major advance in the diag-
nosis of multiple sclerosis (MS). Although neurophys-
iological tests, that of evoked potentials in particu-
lar, have great value in the diagnosis of MS, they have
not been widely used for the diagnosis of MS, despite
the fact that MRI is costly and is available at only a
few health care facilities. Technical advances, togeth-
er with new methods of investigating afferent and
efferent nervous pathways, seem to have increased
the sensitivity of neural dysfunction detection, but
the clinical gains have been modest at best. More
promising is the use of neurophysiological tests to
quantify the extent of white matter involvement1.
The demyelination or sclerosis (scarring) induces a
slowing of nerve impulse propagation. Impaired con-
ductance is reflected in an increase in latency of evok-
ed potentials. Abnormal evoked responses to differ-
ent types of stimuli provide clues for the location of
plaques or lesions, confirm clinically ambiguous le-
sions and confirm the organic basis of symptoms. A
large proportion of patients with established MS also
show lesions of the central auditory pathways, which
can be identified by brainstem auditory evoked po-
tentials (BAEPs), middle-latency auditory evoked po-
tentials (MLAEPs) and late auditory evoked poten-
tials (LAEPs), as well as by using neuroimaging pro-
cedures2-4. Unfortunately, many professionals are not
cognizant of the auditory deficits that may be asso-
ciated with this pathology. As a result, these deficits
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often go undetected, especially if assessment is lim-
ited to a peripheral test battery. Musiek et al.5 found
that 18% of their MS subjects had significant hear-
ing losses, although more than 40% of their subjects
with normal peripheral hearing presented auditory
complaints. They also reported that 80% of their sub-
jects presented an abnormality on at least one audi-
tory test when central as well as peripheral hearing
tests were administered. Celebisoy et al.6 studied
MLAEPs and BAEPs in 30 patients with MS. They
found BAEP abnormalities in 18 of the patients and
MLAEP abnormalities in 22. In 15 of the 30 patients
studied, BAEPs and MLAEPs were both abnormal. In
7 of the 12 patients with normal BAEPs, MLAEPs were
found to be abnormal. Of the 18 patients with abnor-
mal BAEPs, only 3 presented normal MLAEPs. 
The purpose of this paper is to report behavioral
and electrophysiological findings, before and after
corticosteroid therapy, in an MS patient presenting
hearing complaints.
CASE
The patient gave an informed consented for this case
report.
A 27-year-old right-handed man, diagnosed with MS
11 years prior and using interferon beta-1a, presented in
December 2002 an acute crisis during which he experienced
blurred vision and, for the first time, hearing difficulties in
the right ear. The hearing complaints included difficulty
hearing in noisy environments and a lack of tolerance for
loud sounds. One week after the onset of the symptoms,
the patient visited the Speech and Hearing Department at
the University of São Paulo School of Medicine for audio-
logic evaluation. After the first evaluation, the neurologist
prescribed corticosteroid therapy. After seven weeks, the
patient returned for new evaluation involving the same
procedures. 
Pre- and post-treatment audiologic evaluation includ-
ed conventional pure tone audiometry (250-800 Hz), per-
formance-intensity functions, immittance measures, the
speech in noise test and the staggered spondaic word (SSW)
test, as well as measurement of BAEPs, MLAEPs and the
P300 component of the LAEPs. A two-channel audiometer
(GSI 61; Grason Stadler) was used for pure tone audiome-
try, speech audiometry and behavioral tests of central audi-
tory processing. A GSI 33 middle ear analyzer (Grason Sta-
dler) was used for immittance measures.
Electrophysiological procedures were carried out using
Biologic Traveler Express equipment. For BAEP we used rar-
efaction clicks at 80 dB HL, presented at 19 clicks/sec. The
presence and absolute latencies of waves I, III and V, as well
as the interwave latencies I-III, III-V and I-V, were analyzed.
For MLAEP 70-dB HL rarefaction clicks were presented at
10 clicks/sec using the following electrode sites: forehead
(as ground), left and right ears (A1 and A2) and both tem-
poral lobes (C3 and C4). The MLAEP wave Pa latency and
amplitude measures were registered ipsilaterally (C3/A1
and C4/A2) and contralaterally (C3/A2 and C4/A1). For P300
we used clicks at 75 dB HL, presented at 1.1 clicks/sec, to
analyze the presence and latency of P300.
Results – After corticosteroid therapy, pure tone thresh-
olds in the right ear improved by 10-15 dB at all frequen-
cies (Table 1). As can be seen in Table 2, the acoustic reflex-
es in the right ear also improved by 10-15 dB after treat-
Table 1. Pre- and post-treatment pure tone audiometry.
0.25 kHz 0.50 kHz 1 kHz 2 kHz 3 kHz 4 kHz 6 kHZ 8 kHZ
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
AC-RE 20 10 20 5 15 5 15 0 5 0 10 0 10 10 15 5
BC-RE 20 5 15 5 15 0 5 0 10 0
AC-LE 20 10 15 10 5 5 0 0 0 0 10 5 15 10 10 5
BC-LE 15 10 5 5 0 0 0 0 10 5
AC, air conduction; RE, right ear; BC, bone conduction; LE, left ear.
Table 2. Pre- and post-treatment acoustic reflexes.
0.50 kHZ 1 kHz 2 kHz 4 kHZ
Pre Post Pre Post Pre Post Pre Post
IPSI RE 100 85 95 85 95 90 95 90
CONTRA RE 115 105 100 95 105 95 95 85
IPSI LE 95 90 85 85 80 85 80 90
CONTRA LE 95 100 90 95 90 95 85 85
IPSI, ipsilateral; RE, right ear; CONTRA, contralateral; LE, left ear.
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ment. In addition, the speech in noise performance of the
right ear improved after treatment (Table 3). Figure 1 shows
all BAEP waves for both ears before and after treatment.
The Pa amplitudes for all of the electrode sites (C3A1, C3A2,
C4A1 and C4A2) increased after treatment (Fig 2). In Figure
3, it can be seen that there was no significant difference
between pre- and post-treatment values for P300 latency
in either ear.
Table 3. Pre- and post-treatment behavioral evaluation of the
auditory pathway.
Speech in noise test SSW test
Pre Post Pre Post
RE 64% 84% 90% 90%
LE 80% 84% 90% 90%
SSW, staggered spondaic word; RE, right ear; LE, left ear.
Fig 1. BEAPs before and after treatment. LE, left ear; RE, right
ear.
Fig 2. MLAEPs before and after treatment.
Fig 3. P300 before and after treatment. LE, left ear; RE. right
ear.
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DISCUSSION
The patient presented noticeable improvement
in auditory symptoms after corticosteroid therapy.
Although post-treatment improvement was observed
in the pure tone audiometry results, as well as in tho-
se of the acoustic reflex test, it is of note that periph-
eral hearing was found to be within normal limits.
Therefore, had a more thorough hearing examina-
tion not been performed in order to evaluate cen-
tral auditory processing, it would not have been pos-
sible to identify any alterations.
The post-treatment results of the speech in noise
test were normal for the right ear, and the SSW test
results were essentially normal before and after treat-
ment (Table 3). These results confirm the fact that
the patient presented abnormalities at the level of
the brainstem but not at the more central level.
Impairment of binaural processing can occur in
MS due to the demyelination of many pons structu-
res, such as the superior olives and a region between
the two inferior colliculi, that are responsible for the
function involved in processing speech in noise.
In the electrophysiological evaluation of the right
ear, the first BAEP evaluation demonstrated no wave
III and a 2-ms delay (7.84 ms) in absolute latency of
wave V in comparison to the left ear, evidencing
brainstem impairment on the right side. In the sec-
ond evaluation, we noticed a decrease in absolute
latency of wave V (6.84 ms), 1 ms sooner than in the
first evaluation. Matathias et al.2 also reported BAEP
abnormalities in 50% of the MS patients studied.
Walsh, Kane and Butler7 reported that BAEPs are mo-
re likely to be abnormal when demyelination affects
the brainstem clinically, but they can also detect “si-
lent” lesions in approximately 40% of patients who
do not have symptoms or signs of brainstem involve-
ment. Delay is probably indicative of the MS-related
demyelination of the auditory pathways. It is impor-
tant to remember that vascular, inflammatory, neu-
rodegenerative, metabolic and infectious conditions
may mimic MS lesions on MRIs. Therefore, a diagno-
sis of MS may not be made based on the presence of
MRI lesions alone and requires corroboration through
appropriate clinical or other tests. When MS presents
as a clinically isolated syndrome, the criteria for disse-
mination over time must be met in order for a defin-
itive clinical diagnosis of MS to be made. Dissemi-
nation in space may often be demonstrated by evok-
ed potential testing. 
Bergamaschi et al.3 found that BAEP abnormali-
ties decreased progressively to normalization that
coincided with clinical recovery. Although, for our
patient, we had no access to BAEP test results obtain-
ed prior to symptom onset, recovery was coincident
with the decreased wave V latency. Therefore, we
strongly recommend that all patients diagnosed with
MS (even those presenting no auditory symptoms)
be submitted to BAEP testing as a baseline evalua-
tion for later comparison.
The first MLAEP test revealed ear and electrode
effects for the right ear. The ear effect was not found
in the second evaluation. Myelin not only protects
nerve fibers but enables their function. When myelin
or nerve fiber is damaged or destroyed, the ability
of the nerves to conduct electrical impulses to and
from the brain is disrupted, and this produces the
various symptoms of MS.
Celebisoy et al.6 found that 60% of the patients
with confirmed brainstem involvement presented
BAEP abnormalities. In addition, the MLAEP results
were abnormal in 73.3% of the patients.They con-
cluded that the use of BAEP measures in combina-
tion with MLAEP measures is a more comprehensive
means of evaluating brain function in such patients.
Another study8 showed that up to 79% of MS pati-
ents with clinical evidence of brain stem involvement
presented abnormal BAEPs. 
The P300 and SSW test results were within nor-
mal limits before and after treatment, demonstrat-
ing that the disease had not affected the higher lev-
els (cortical areas) of the auditory pathway. However
some researchers have found abnormalities in the
LAEPs of patients with MS4,9,10. In such cases, one
might infer that the disease had not affected the au-
ditory areas related to the generation of such poten-
tial. Therefore, the behavioral and electrophysiolog-
ical results were in agreement, contributing to the
determination of the site of lesion2,3,4,6,10.
All tests of central auditory function (behavioral
and electrophysiology) were good predictors of le-
sion. We feel that the results of this case study are
significant since impairment of at least two distinct,
unrelated functions is necessary in order to establish
a diagnosis of MS. Auditory complaints are quite com-
mon and almost always unspecific. Therefore, physi-
cians are typically more attentive to the more fre-
quently reported visual alterations, to the detriment
of the auditory complaints, which, as a consequence,
are rarely investigated. There is no doubt that MRI
brain scans represent an advance in the diagnosis of
MS, which is a dynamic disease, lesions always devel-
ops, and many of those lesions are clinically silent.
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Therefore, we must prioritize the allocation of exist-
ing resources. It is feasible to use those resources with
precision, thereby achieving two main objectives: the
follow-up treatment of pre-established profiles; and
the diagnosis of new lesions that might develop.
Using central auditory tests (behavioral and elec-
trophysiological), we were able to identify the exact
location of the impairment (brainstem), which was
in agreement with the patient complaint. We found
the speech in noise test and the BAEP test both to
be definitely appropriate in confirming brainstem
lesions.
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